References
- American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders: DSM-5™5th edWashington, DCAmerican Psychiatric Association2013
- VriendsNBoltOCKunzSMSocial anxiety disorder, a lifelong disorder? A review of the spontaneous remission and its predictorsActa Psychiatr Scand2014130210912224506164
- SteinMBSteinDJSocial anxiety disorderLancet200837196181115112518374843
- SareenJCoxBJAfifiTOAnxiety disorders and risk for suicidal ideation and suicide attempts: a population-based longitudinal study of adultsArch Gen Psychiatry200562111249125716275812
- AsakuraSInoueTKitagawaNSocial Anxiety/Taijin-Kyofu Scale (SATS): development and psychometric evaluation of a new instrumentPsychopathology20124529610122269587
- YamashitaITaijin-kyofu or Delusional Social PhobiaSapporoHokkaido University Press1993
- SareenJSteinMA review of the epidemiology and approaches to the treatment of social anxiety disorderDrugs200059349750910776832
- SwinsonRPClinical practice guidelines. Management of anxiety disordersCan J Psychiatry200651235S41S
- BandelowBZoharJHollanderEWorld Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders – first revisionWorld J Biol Psychiatry20089424831218949648
- BaldwinDSAndersonIMNuttDJEvidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British association for psychopharmacologyJ Psychopharmacol201428540343924713617
- SteinDJBaldwinDSBandelowBA 2010 evidence-based algorithm for the pharmacotherapy of social anxiety disorderCurr Psychiatry Rep201012547147720686872
- LaderMStenderKBürgerVNilREfficacy and tolerability of escitalopram in 12- and 24-week treatment of social anxiety disorder: randomized, double-blind, placebo-controlled, fixed-dose studyDepress Anxiety200419424124815274173
- NakasaHAriyoshiNKitadaM1. [Drug metabolizing enzymes, e. CYP genotypes and expression regulation]SawadaYGenotypes and Pharmacokinetics/Effects – New Developments in the 21st Century in Tailor-made Drug Therapy1st edOsakaIyaku (Medicine and Drug) Journal Co, Ltd2001158171 Japanese
- SatoHHirayasuYEscitalopram clinical pharmacokinetic study – Single dose and multiple dose administration (Japan)Jpn J Clin Psychopharmacol2011145839855 Japanese
- American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders, Text Revision: DSM-IV-TR™4th edWashington, DCAmerican Psychiatric Association2000
- OtsuboTMiyaokaHKamijimaKM.I.N.I. Brief Diagnostic Structured Interview for Mental DiseaseTokyoSeiwa Shoten Publishers2000 Japanese
- AsakuraSInoueSSasakiFReliability and validity of the Japanese version of the Liebowitz Social Anxiety ScaleSeishin Igaku (Clinical Psychiatry)2002441010771084 Japanese
- MontgomerySAAsbergMA new depression scale designed to be sensitive to changeBr J Psychiatry1979134382389444788
- PosnerKBrownGKStanleyBThe Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adultsAm J Psychiatry2011168121266127722193671
- YoshidaTOtsuboTTsuchidaHWadaYKamijimaKFukuiKReliability and validity of the Sheehan Disability Scale – Japanese versionJpn J Clin Psychopharmacol200471016451653 Japanese
- WadeADespiegelNHeldbo ReinesEEscitalopram in the long-term treatment of major depressive disorderAnn Clin Psychiatry2006182838916754413